The table below shows PHIBRO ANIMAL HEALTH CORP's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q4 2025
Q3 2025
Q1 2025
Q4 2024
Q3 2024
Revenue
$383.54M
$373.91M
$363.89M
$347.82M
$309.26M
$260.43M
Cost of revenue
$257.87M
$241.25M
$244.11M
$243.26M
$207.39M
$176.94M
Gross profit
$125.67M
$132.66M
$119.78M
$104.57M
$101.87M
$83.50M
R&D
-
-
-
-
-
-
PAHC annual revenue (10-K history)
PHIBRO ANIMAL HEALTH CORP reported annual revenue of $1.30B for fiscal year 2025. That is up 27.4% from $1.02B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $751.53M (FY 2016) to $1.30B. Figures come from the company's audited annual reports as filed with the SEC.